CAS: 91-85-0 - thonzylamine
Formel:C16H22N4O
InChl:InChI=1S/C16H22N4O/c1-19(2)11-12-20(16-17-9-4-10-18-16)13-14-5-7-15(21-3)8-6-14/h4-10H,11-13H2,1-3H3
InChI Key:InChIKey=GULNIHOSWFYMRN-UHFFFAOYSA-N
SMILES:N=1C=CC=NC1N(CC2=CC=C(OC)C=C2)CCN(C)C
- Synonyme:
- 1,2-Ethanediamine N1-[(4-methoxyphenyl)methyl]-N2,N2-dimethyl-N1-2-pyrimidinyl-
- 1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N′,N′-dimethyl-N-2-pyrimidinyl-
- 1,2-Ethanediamine, N<sup>1</sup>-[(4-methoxyphenyl)methyl]-N<sup>2</sup>,N<sup>2</sup>-dimethyl-N<sup>1</sup>-2-pyrimidinyl-
- 2-(P-Anisyl(Pyrimidin-2-Yl)Amino)Ethyldimethylamine
- 2-[p-Methoxybenzyl-(2-dimethylaminoethyl)amino]pyrimidine
- N-(4-methoxybenzyl)-N',N'-dimethyl-N-(pyrimidin-2-yl)ethane-1,2-diamine
- N<sup>1</sup>-[(4-Methoxyphenyl)methyl]-N<sup>2</sup>,N<sup>2</sup>-dimethyl-N<sup>1</sup>-2-pyrimidinyl-1,2-ethanediamine
- Neohetramine
- Pyrimidine, 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
thonzylamine REF: IN-DA006DPICAS: 91-85-0 | 95% | Nachfragen | Di 10 Dez 24 | |
Thonzylamine REF: 4Z-T-138001CAS: 91-85-0 | - - - | Nachfragen | Di 10 Dez 24 | |
Thonzylamine REF: TM-T4563CAS: 91-85-0 | 99.45% | 35,00 €~268,00 € | Mo 16 Dez 24 | |
Thonzylamine REF: 3D-AAA09185CAS: 91-85-0 | Min. 95% | Nachfragen | Di 21 Jan 25 | |
Thonzylamine REF: TR-T397005CAS: 91-85-0 | - - - | - - - | Ausgelaufenes produkt |
Ref: IN-DA006DPI
1g | Nachfragen | ||
5g | Nachfragen | ||
25mg | 177,00 € | ||
50mg | 221,00 € | ||
100mg | 484,00 € | ||
250mg | 580,00 € |
Ref: 4Z-T-138001
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen | ||
100mg | Nachfragen |
Thonzylamine
Ref: TM-T4563
2mg | 35,00 € | ||
5mg | 51,00 € | ||
10mg | 73,00 € | ||
25mg | 124,00 € | ||
50mg | 183,00 € | ||
100mg | 268,00 € |
Thonzylamine
Ref: 3D-AAA09185
1mg | 148,00 € | ||
10mg | 558,00 € |
Thonzylamine
Ref: TR-T397005
1mg | Ausgelaufen | Anforderung von Informationen | |
10mg | Ausgelaufen | Anforderung von Informationen |